Innovating Safer Solutions for the Treatment of Metastatic Breast Cancer

TTC Oncology LLC was founded in July 2015. The Company has a worldwide license from the University of Illinois Chicago (UIC) covering novel composition of use in therapeutic modulation of the estrogen receptor (ER) in ER+ breast cancer.

TTC Oncology LLC is directed by Members, who own equity units in the company, and controlled by the Company’s financial investor, the Controlling Member.

TTC Oncology is supported by expert consultants with many decades of experience in pharma and biotech.

You can support TTC Oncology by helping make this life changing solution available to the millions of patients who will be diagnosed with Breast Cancer in the years to come.